Imaging Tumor Angiogenesis Using Contrast-Enhanced Magnetic Resonance Imaging

  • R. C. Brasch
Conference paper
Part of the Syllabus book series (SYLLABUS)


Magnetic resonance imaging (MRI) enhanced with contrast media has the potential to measure the level of angiogenesis in cancers and to monitor the immediate effects of drugs intended to inhibit angiogenesis. To appreciate the significance of such potential, it is necessary to first understand what is angiogenesis and why it is receiving so much attention.


Permeability Surface Placenta Growth Factor Histologic Assay Contrast Medium Concentration Macromolecular Contrast Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Folkman J (1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4–6Google Scholar
  2. 2.
    Liotta LA, Kleinerman J, Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 34: 997–1004PubMedGoogle Scholar
  3. 3.
    Jain R, Gerlowski L (1984) Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol 5: 115–170CrossRefGoogle Scholar
  4. 4.
    Fidler 1, Ellis L (1994) The implication of angiogenesis for the biology and therapy of cancer metastases. Cell 79: 185188Google Scholar
  5. 5.
    Weidner N, Semple J, Welch W, Folkman J (1991) Tumor angiogensis and metasasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1–8PubMedCrossRefGoogle Scholar
  6. 6.
    Weidner N (1995) Intratumoral microvascular density as a prognostic factor in cancer. Am J Pathol 147: 9–19PubMedGoogle Scholar
  7. 7.
    Folkman J (1992) Introduction: angiogenesis and cancer. Semin Cancer Biol 3: 47–48Google Scholar
  8. 8.
    Heywang-Köbrunner S (1994) Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 29: 94–104PubMedCrossRefGoogle Scholar
  9. 9.
    Aicher KP, Dupon JW, White DL, et al. (1990) Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Cancer Res 50: 7376–7381PubMedGoogle Scholar
  10. 10.
    van Dijke C, Brasch R, Roberts T, et al. (1996) Mammary carcinoma model: correlation of macromolecular contrast enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198: 813–818PubMedGoogle Scholar
  11. 11.
    Schwickert H, Stiskal M, Roberts T, et al. (1996) Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of pre-irradiation on the tumor delivery of chemotherapy. Radiology 198: 893–898PubMedGoogle Scholar
  12. 12.
    Cohen F, Kuwatsuru R, Shames D, et al. (1995) Contrast enhanced MRI estimation of altered capillary permeability in experimental mammary carcinomas following irradiation. Invest Radiol 29: 970–977CrossRefGoogle Scholar
  13. 13.
    Daldrup H, Shames D, Wendland M, et al. (1998) Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macro-molecular and small molecular contrast media. Am J Roentgen 171: 941–949Google Scholar
  14. 14.
    Schmiedl U, Ogan MD, Paajanen H. et al. (1987) Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 162: 205–210PubMedGoogle Scholar
  15. 15.
    Kuwatsuru R, Shames D, Mühler A, et al. (1993) Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 30: 76–81PubMedCrossRefGoogle Scholar
  16. 16.
    Schwickert H, Stiskal M, van Dijke C, et al. (1995) Tumor angiography using high resolution 3D MRI: comparison of Gd-DTPA and a macromolecular blood pool contrast agent. Acad Radiol 2: 851–858PubMedCrossRefGoogle Scholar
  17. 17.
    Kaiser W, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 170: 681–686PubMedGoogle Scholar
  18. Stack JP, Redmond OM, Codd MB, Dervan PA. Ennis JT (1990) Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 174: 491–494Google Scholar
  19. 19.
    Buadu L, Murakami J. Murayama S, Hashiguchi N, Masuda K, Toyoshima S (1996) Correlation between contrast-enhanced MR imaging of the breast and tumor angiogenesis: a quantitative and qualitative study. In: Annual Meeting American Roengen Ray Society. San Diego, Abstract 58Google Scholar
  20. 20.
    Tofts P, Berkowitz B, Schnall M (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 33: 564–568PubMedCrossRefGoogle Scholar
  21. 21.
    Stomper P. Herman S, Klippenstein D, et al. (1995) Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197: 387–395PubMedGoogle Scholar
  22. 22.
    Weinreb J, Newstead G (1995) MR imaging of the breast. Radiology 196: 593–610PubMedGoogle Scholar
  23. 23.
    Spraggins T, de Paredes E, DeAngelis G (1993) Three-dimensional keyhole imaging: application to dynamic contrast-enhanced MRI of the breast. Proceedings of the Society of Magnetic Resonance in Medicine. Berkeley, Abstract 115Google Scholar
  24. 24.
    Renkin EM (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197: 1205–1210PubMedGoogle Scholar
  25. 25.
    Crone C (1963) The permeability of capillaries in various organs determined by the use of the “indicator diffusion” method. Acta Physiol Scand 58: 292–305PubMedCrossRefGoogle Scholar
  26. 26.
    Jain R (1987) Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6: 559–593PubMedCrossRefGoogle Scholar
  27. 27.
    Gerlowski LE, Jain RK (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31: 288–305PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • R. C. Brasch
    • 1
  1. 1.Contrast Media Laboratory and Center for Pediatric Pharmaceutical and Molecular Imaging, Department of RadiologyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations